These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8790203)

  • 21. Radionuclide therapy for painful bone metastases. An Italian multicentre observational study. Writing Committee of an Ad Hoc Study Group.
    Piffanelli A; Dafermou A; Giganti M; Colamussi P; Pizzocaro C; Bestagno M;
    Q J Nucl Med; 2001 Mar; 45(1):100-7. PubMed ID: 11456368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pain therapy with rhenium-186 HEDP in multiple bone metastases].
    Palmedo H; Bender H; Schomburg A; Grünwald F; Schöneich G; Zamorra P; Reichmann K; Dierke-Dzierzon C; Mallmann P; Biersack HJ
    Nuklearmedizin; 1996 Apr; 35(2):63-7. PubMed ID: 8721578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone pain palliation with 85Sr therapy.
    Giammarile F; Mognetti T; Blondet C; Desuzinges C; Chauvot P
    J Nucl Med; 1999 Apr; 40(4):585-90. PubMed ID: 10210217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancer.
    Maxon HR; Schroder LE; Thomas SR; Hertzberg VS; Deutsch EA; Scher HI; Samaratunga RC; Libson KF; Williams CC; Moulton JS
    Radiology; 1990 Jul; 176(1):155-9. PubMed ID: 1693784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase 2 study of a high dose of 186Re-HEDP for bone pain palliation in patients with widespread skeletal metastases.
    Pirayesh E; Amoui M; Mirzaee HR; Tabei F; Rakhsha A; Kalantari BA; Shafiei B; Assadi M; Asli IN
    J Nucl Med Technol; 2013 Sep; 41(3):192-6. PubMed ID: 23918612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative bone single-photon emission computed tomography for prediction of pain relief in metastatic bone disease treated with rhenium-186 etidronate.
    Israel O; Keidar Z; Rubinov R; Iosilevski G; Frenkel A; Kuten A; Betman L; Kolodny GM; Yarnitsky D; Front D
    J Clin Oncol; 2000 Jul; 18(14):2747-54. PubMed ID: 10894875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative efficacy of 32P and 89Sr in palliation in skeletal metastases.
    Nair N
    J Nucl Med; 1999 Feb; 40(2):256-61. PubMed ID: 10025832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rhenium-186 HEDP: palliative radionuclide therapy of painful bone metastases. Preliminary results.
    Schoeneich G; Palmedo H; Dierke-Dzierzon C; Müller SC; Biersack HJ
    Scand J Urol Nephrol; 1997 Oct; 31(5):445-8. PubMed ID: 9406304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy.
    Liepe K; Kropp J; Hliscs R; Franke WG
    Clin Nucl Med; 2000 Nov; 25(11):901-4. PubMed ID: 11079588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient relief of metastatic cancer bone pain by oral administration of etidronate.
    Iwamoto J; Takeda T; Ichimura S
    J Bone Miner Metab; 2002; 20(4):228-34. PubMed ID: 12115069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of rhenium-188, rhenium-186-HEDP and strontium-89 in palliation of painful bone metastases].
    Liepe K; Franke WG; Kropp J; Koch R; Runge R; Hliscs R
    Nuklearmedizin; 2000 Sep; 39(6):146-51. PubMed ID: 11057405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rhenium-188(Sn)HEDP for treatment of osseous metastases.
    Maxon HR; Schroder LE; Washburn LC; Thomas SR; Samaratunga RC; Biniakiewicz D; Moulton JS; Cummings D; Ehrhardt GJ; Morris V
    J Nucl Med; 1998 Apr; 39(4):659-63. PubMed ID: 9544677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck.
    Colnot DR; Quak JJ; Roos JC; van Lingen A; Wilhelm AJ; van Kamp GJ; Huijgens PC; Snow GB; van Dongen GA
    J Nucl Med; 2000 Dec; 41(12):1999-2010. PubMed ID: 11138685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Introduction of a new semi-quantitative index with predictive implications in patients with painful osseous metastases after (186)Re-HEDP therapy.
    Zafeirakis A; Zissimopoulos A; Baziotis N; Limouris GS
    Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):91-102. PubMed ID: 21068716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rhenium-186-labeled hydroxyethylidene diphosphonate dosimetry and dosing guidelines for the palliation of skeletal metastases from androgen-independent prostate cancer.
    Graham MC; Scher HI; Liu GB; Yeh SD; Curley T; Daghighian F; Goldsmith SJ; Larson SM
    Clin Cancer Res; 1999 Jun; 5(6):1307-18. PubMed ID: 10389913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pain therapy in multiple bone metastases in breast carcinoma with rhenium 186 HEDP].
    Hauswirth AE; Palmedo H; Dierke-Dzierzon C; Biersack HJ; Krebs D
    Zentralbl Gynakol; 1998; 120(2):83-6. PubMed ID: 9531713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Advanced prostate carcinoma: systemic radionuclide therapy of bone metastasis with rhenium-168-hydroxyethylidine diphosphonate].
    Lerch H
    Strahlenther Onkol; 1998 Jul; 174(7):384-5. PubMed ID: 9689963
    [No Abstract]   [Full Text] [Related]  

  • 38. Rhenium-188-HEDP in the palliative treatment of bone metastases.
    Liepe K; Hliscs R; Kropp J; Grüning T; Runge R; Koch R; Knapp FF; Franke WG
    Cancer Biother Radiopharm; 2000 Jun; 15(3):261-5. PubMed ID: 10941533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Palliative treatment of painful disseminated bone metastases with 186Rhenium-HEDP in patients with lung cancer.
    Leondi AH; Souvatzoglou MA; Rapti AS; Leontopoulou SA; Papadaki EK; Datseris EI; Anagnostopoulou US; Zerva CJ
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):211-9. PubMed ID: 15499295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical experience with rhenium-188 HEDP therapy for metastatic bone pain].
    Róka R; Séra T; Pajor L; Thurzó L; Láng J; Csernay L; Pávics L
    Orv Hetil; 2000 May; 141(19):1019-23. PubMed ID: 10846424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.